{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T15:30:14Z","timestamp":1791819014008,"version":"4.3.4"},"reference-count":20,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","nwhjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nursing for Women's Health"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.nwh.2022.01.003","type":"journal-article","created":{"date-parts":[[2022,2,5]],"date-time":"2022-02-05T15:54:40Z","timestamp":1644076480000},"page":"242-249","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Combined Oral Contraceptive Use and Breast Cancer Risk: Select Considerations for Clinicians"],"prefix":"10.1016","volume":"26","author":[{"given":"Karly","family":"Smrekar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole M.","family":"Lodise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nwh.2022.01.003_bib1","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/sj.bjc.6600691","article-title":"Hormonal content and potency of oral contraceptives and breast cancer risk among young women","volume":"88","author":"Althuis","year":"2003","journal-title":"British Journal of Cancer"},{"issue":"15","key":"10.1016\/j.nwh.2022.01.003_bib5","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1158\/0008-5472.CAN-13-3400","article-title":"Recent oral contraceptive use by formulation and breast cancer risk among women 20\u201349 years of age","volume":"74","author":"Beaber","year":"2014","journal-title":"Cancer Research"},{"key":"10.1016\/j.nwh.2022.01.003_bib6","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1002\/ijc.31266","article-title":"Progestin-only and combined oral contraceptives and receptor-defined premenopausal breast cancer risk: The Norwegian Women and Cancer Study","volume":"142","author":"Busund","year":"2018","journal-title":"International Journal of Cancer"},{"issue":"9017","key":"10.1016\/j.nwh.2022.01.003_bib12","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/S0140-6736(96)90806-5","article-title":"Breast cancer and hormonal contraceptives: Collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies","volume":"347","year":"1996","journal-title":"The Lancet"},{"key":"10.1016\/j.nwh.2022.01.003_bib13","first-page":"1","article-title":"Current contraceptive use and variation by selected characteristics among women aged 15\u201344: United States, 2011\u20132013","volume":"86","author":"Daniels","year":"2015","journal-title":"National Health Statistics Reports"},{"key":"10.1016\/j.nwh.2022.01.003_bib14","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.critrevonc.2019.03.001","article-title":"Breast cancer risk of hormonal contraception: Counselling considering new evidence","volume":"137","author":"Del Pup","year":"2019","journal-title":"Critical Reviews in Oncology\/Hematology"},{"key":"10.1016\/j.nwh.2022.01.003_bib15","author":"Franceschini"},{"issue":"11","key":"10.1016\/j.nwh.2022.01.003_bib16","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1158\/1055-9965.EPI-13-0298","article-title":"Oral contraceptive use and risk of breast, cervical, colorectal, and endometrial cancers: A systematic review","volume":"22","author":"Gierisch","year":"2013","journal-title":"Cancer Epidemiology, Biomarkers & Prevention"},{"issue":"14","key":"10.1016\/j.nwh.2022.01.003_bib17","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1001\/jama.284.14.1791","article-title":"Risk of breast cancer with oral contraceptive use in women with a family history of breast cancer","volume":"284","author":"Grabrick","year":"2000","journal-title":"JAMA"},{"issue":"23","key":"10.1016\/j.nwh.2022.01.003_bib19","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1056\/NEJMe1709636","article-title":"Oral contraceptives and the small increased risk of breast cancer","volume":"377","author":"Hunter","year":"2017","journal-title":"New England Journal of Medicine"},{"issue":"10","key":"10.1016\/j.nwh.2022.01.003_bib20","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1158\/1055-9965.EPI-10-0747","article-title":"Oral contraceptive use and breast cancer: A prospective study of young women","volume":"19","author":"Hunter","year":"2010","journal-title":"Cancer Epidemiology, Biomarkers & Prevention"},{"key":"10.1016\/j.nwh.2022.01.003_bib21","doi-asserted-by":"crossref","first-page":"580.e1","DOI":"10.1016\/j.ajog.2017.02.002","article-title":"Lifetime cancer risk and combined oral contraceptives: The Royal College of General Practitioners\u2019 Oral Contraception Study","volume":"216","author":"Iversen","year":"2017","journal-title":"American Journal of Obstetrics & Gynecology"},{"key":"10.1016\/j.nwh.2022.01.003_bib22","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1056\/NEJMcp0708481","article-title":"Hormonal contraception in women of older reproductive age","volume":"358","author":"Kaunitz","year":"2008","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.nwh.2022.01.003_bib23","first-page":"1375","article-title":"Use of oral contraceptives and breast cancer risk: The Norwegian-Swedish women\u2019s lifestyle and health cohort study","volume":"11","author":"Kumle","year":"2002","journal-title":"Cancer Epidemiology, Biomarkers & Prevention"},{"issue":"26","key":"10.1016\/j.nwh.2022.01.003_bib24","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1056\/NEJMoa013202","article-title":"Oral contraceptives and the risk of breast cancer","volume":"346","author":"Marchbanks","year":"2002","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1016\/j.nwh.2022.01.003_bib25","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1001\/jamaoncol.2017.4942","article-title":"Modification of the associations between duration of oral contraceptive use and ovarian, endometrial, breast, and colorectal cancers","volume":"4","author":"Michels","year":"2018","journal-title":"JAMA Oncology"},{"issue":"23","key":"10.1016\/j.nwh.2022.01.003_bib26","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1056\/NEJMoa1700732","article-title":"Contemporary hormonal contraception and the risk of breast cancer","volume":"377","author":"Morch","year":"2017","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1016\/j.nwh.2022.01.003_bib30","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/aje\/kwn360","article-title":"A\u00a0case-control study of oral contraceptive use and incident breast cancer","volume":"169","author":"Rosenberg","year":"2009","journal-title":"American Journal of Epidemiology"},{"issue":"1","key":"10.1016\/j.nwh.2022.01.003_bib31","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10549-015-3663-1","article-title":"Progestin and breast cancer risk: A systematic review","volume":"155","author":"Samson","year":"2016","journal-title":"Breast Cancer Research and Treatment"},{"issue":"1","key":"10.1016\/j.nwh.2022.01.003_bib32","first-page":"41","article-title":"Non-contraceptive benefits of oral hormonal contraceptives","volume":"11","author":"Schindler","year":"2013","journal-title":"International Journal of Endocrinology and Metabolism"}],"container-title":["Nursing for Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1751485122000034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1751485122000034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T21:43:14Z","timestamp":1761687794000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1751485122000034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S1751485122000034"],"URL":"https:\/\/doi.org\/10.1016\/j.nwh.2022.01.003","relation":{},"ISSN":["1751-4851"],"issn-type":[{"value":"1751-4851","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combined Oral Contraceptive Use and Breast Cancer Risk: Select Considerations for Clinicians","name":"articletitle","label":"Article Title"},{"value":"Nursing for Women's Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nwh.2022.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 AWHONN","name":"copyright","label":"Copyright"}]}}